HIF1A and type 1 diabetes mellitus: An indirect approach using YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole], a HIF-1 inhibitor, reduced glomerular hypertrophy and AGE-tissue modifications in the type 1 diabetes mouse model [6].